|
|
Volumn 3, Issue 8, 2013, Pages 831-
|
|
Trebananib boosts PFS in ovarian cancer
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMG 780;
ANGIOGENESIS INHIBITOR;
ANGIOPOIETIN 1;
ANGIOPOIETIN 2;
BEVACIZUMAB;
PACLITAXEL;
PLACEBO;
SUNITINIB;
TREBANANIB;
UNCLASSIFIED DRUG;
ANTIANGIOGENIC ACTIVITY;
HUMAN;
NOTE;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PROGRESSION FREE SURVIVAL;
RECURRENT DISEASE;
SIGNAL TRANSDUCTION;
|
|
EID: 84881539154
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2013-099 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|